Total Funding
90
88
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
70387
Cellemedy is a biotechnology company that develops next-generation therapeutic proteins to replace conventional antibody treatments.
- Hachul Kim: CEO
About the Company
Cellemedy is a biotechnology company committed to developing next-generation therapeutic proteins aimed at replacing conventional antibody treatments. Their proprietary platform offers enhanced antigen-binding capabilities and broader applicability compared to traditional antibodies. Its mission is to advance human health by creating innovative
biopharmaceuticals that improve treatment outcomes across various medical conditions.
